Chronic lymphocytic leukemia (CLL) B cells and tumor microenvironment (TME) bystander cells incite a tolerogenic environment through soluble factors (e.g., IL-10) and immune inhibitory molecules (e.g., PD-L1, LAG3) (1). The gene discussed is IL10; the disease is B-cell chronic lymphocytic leukemia.